Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma - Haluska, P; Worden, F; Olmos, D (Cancer Chemother Pharmacol, 2010)
et al.